Medicine guide

Spevigo 150 mg/1ml

As listed in the register: Spevigo 150 mg/1ml, Injektionslösung in einer Fertigspritze

150 mg/1ml ·

  • Prescription only
  • Cancer treatments and immune-system medicines
Active substance
Spesolimabum
Made by
Leo Pharmaceutical Products Sarath Ltd.

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

  • Vorbeugung von Krankheitsschüben der generalisierten pustulösen Psoriasis bei Erwachsenen und Jugendlichen ab 12 Jahren mit mindestens 40 kg Körpergewicht

From the official label · 2026-09-30 · Swissmedic

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

European UnionNo exact match for this strength and form

SpainNo exact match for this strength and form

CanadaNo exact match for this strength and form

NetherlandsNo exact match for this strength and form

Details

Made byLeo Pharmaceutical Products Sarath Ltd.
Active substanceSpesolimabum
Used inCancer treatments and immune-system medicines
Strength150 mg/1ml
ClassificationL04AC22 · Cancer treatments and immune-system medicines
Dispensing (as stated by the register)Abgabekategorie B
Name in the registerSpevigo 150 mg/1ml, Injektionslösung in einer Fertigspritze
Packs2 Fertigspritze(n)
Zulassungsnummer69579
Dosisstärke1

Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician

Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.